上海市胰腺肿瘤研究所成立

2017-05-16 医学论坛网 医学论坛网

5月13日,在上海举行的第3届中国胰腺癌多学科高峰论坛上,由复旦大学附属肿瘤医院牵头,上海市瑞金医院、上海市华山医院、上海市华东医院、复旦大学上海医学院等共同参与的上海市胰腺肿瘤研究所正式成立。这是一个跨专业、多学科、临床及科研相结合的学术机构,也是汇集本地最佳医疗资源,申城首家集诊断、治疗、基础研究于一体的胰腺肿瘤临床及转化医学研究机构。 北京协和医院赵玉沛院士应邀任学术委员会名誉主任,复旦大

5月13日,在上海举行的第3届中国胰腺癌多学科高峰论坛上,由复旦大学附属肿瘤医院牵头,上海市瑞金医院、上海市华山医院、上海市华东医院、复旦大学上海医学院等共同参与的上海市胰腺肿瘤研究所正式成立。这是一个跨专业、多学科、临床科研相结合的学术机构,也是汇集本地最佳医疗资源,申城首家集诊断、治疗、基础研究于一体的胰腺肿瘤临床及转化医学研究机构。


北京协和医院赵玉沛院士应邀任学术委员会名誉主任,复旦大学附属肿瘤医院倪泉兴教授任学术委员会主任。

据该所所长、复旦大学附属肿瘤医院胰腺外科主任虞先濬教授介绍,胰腺癌素有“癌王”之称,发病率呈日益高发之势,据WHO预计,到2030年胰腺癌在恶性实体肿瘤死亡病例中,将超过肝癌跃升第二。胰腺癌因隐匿性强,早期诊断困难,手术切除率低,致死率极高,其诊治已成为亟需攻克的重大医学难题。

上海市胰腺肿瘤研究所成立后,将规范胰腺癌淋巴结清扫范围,提高胰腺手术的根治性,因超过半数的胰腺癌病人均存在淋巴结转移,而淋巴转移是胰腺癌的重要预后因素。规范手术清扫范围,开展个体化清扫,可使淋巴转移患者的中位生存期提高30%,有效提高手术根治性。

胰腺癌手术难度大、风险高,目前临床上对其手术指征的判断完全依据CT显示的肿瘤大小、血管侵犯程度来决定,缺乏基于肿瘤生物学特性的筛选与甄别,此导致目前接受手术的患者中存在一部分“手术不获益”亚群(即原发肿瘤切除后,短期内即因转移复发而死亡,手术根治并不能带来生存获益)。因此,为改善预后,研究术前根据其生物学特性预测手术疗效,甄别出这部分患者进行术前干预治疗,成为临床关注的焦点。

复旦大学附属肿瘤医院胰腺外科曾开展流行病学研究,发放流行病学调查表,获得了3000余份国内胰腺肿瘤患者的饮食、生活方式等信息,今后将进一步进行胰腺肿瘤流行病学调查研究,以探索国内胰腺癌发病特点,探索个体化治疗之路。

据悉,胰腺神经内分泌肿瘤其异质性极强,临床诊治十分复杂,但目前胰腺神经内分泌肿瘤国际常用临床分期指标互相矛盾、不实用等现状,建立一个统一、实用、准确的临床分期系统,以指导临床诊治方案的制定就显得尤为重要。因此,研究所将开展多中心、大数据研究,以进一步发现现行分期系统的漏洞与错误,提出更简洁准确、有利于指导临床实践的新分期系统。

虞先濬表示,未来将联合多方优势力量,进一步注重科研和临床的应用和转化,强强联合,组织攻关研究,着力提高胰腺肿瘤规范化综合诊治体系;探索拓展专科化、规范化的发展模式,力争在5-10年内将研究所建成国际知名的临床和基础研究基地。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-17 tt199

    好学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-16 135****7952平儿

    分享了。。。。。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-16 1e1b8538m79(暂无匿称)

    值得祝贺,希望再接再厉

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-16 6888

    红魔look五一

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-16 王国安

    祝贺,多学科研究胰腺癌,形成规范化治疗体系。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1688932, encodeId=04e41688932eb, content=<a href='/topic/show?id=c2d88399372' target=_blank style='color:#2F92EE;'>#胰腺肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83993, encryptionId=c2d88399372, topicName=胰腺肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c44328685072, createdName=ms6980045490879608, createdTime=Thu May 25 15:29:00 CST 2017, time=2017-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809866, encodeId=4d9d18098664c, content=<a href='/topic/show?id=a79083995c5' target=_blank style='color:#2F92EE;'>#胰腺肿瘤研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83995, encryptionId=a79083995c5, topicName=胰腺肿瘤研究所)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Thu Sep 21 18:29:00 CST 2017, time=2017-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1801037, encodeId=b311180103e20, content=<a href='/topic/show?id=79cfe339533' target=_blank style='color:#2F92EE;'>#研究所#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73395, encryptionId=79cfe339533, topicName=研究所)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f63175, createdName=nian.wang1982, createdTime=Wed Dec 27 15:29:00 CST 2017, time=2017-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443936, encodeId=d01a144393633, content=<a href='/topic/show?id=e7601992ea4' target=_blank style='color:#2F92EE;'>#上海市#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19927, encryptionId=e7601992ea4, topicName=上海市)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erZjNAt5tmhEibeth6ic6albyTSZPiaJWo65S17HKWhSicCsY9SmjRJgPut2nqfvkiblrkZtv1T8vPSCAQ/132, createdBy=ad4d5130176, createdName=ms3046638856685384, createdTime=Thu May 18 01:29:00 CST 2017, time=2017-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=199059, encodeId=d47f1990592c, content=好学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuLuc8S5RMt9ZExKtFteCNL6gK27WrafW6OC8OZkF3dic4lHUf2OxZiaWFhEfNtNPFC8AWia2uJm8TLQ/0, createdBy=08cc2048658, createdName=tt199, createdTime=Wed May 17 07:01:30 CST 2017, time=2017-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198888, encodeId=71351988883b, content=分享了。。。。。, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Neru1qt53a14aACuSzg3TZhkTcsPYVibyHibhTZ5L4k9qIBWiaej4lgomIsGptf8N16E4mTuIq2DVdJXjPjmwZKrLib/0, createdBy=5a0f2055853, createdName=135****7952平儿, createdTime=Tue May 16 19:10:58 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198883, encodeId=116e19888338, content=值得祝贺,希望再接再厉, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Tue May 16 18:43:28 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198863, encodeId=f3aa198863d7, content=红魔look五一, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib18tWbCzYcEibw6Ro7WIJDMuc2wJMj17F3Oj2d6Faia1LawEktGVQSxLd9FMILIQYwDLUK9u9WKDap5VY87R0GjeZ/0, createdBy=0acd1864050, createdName=6888, createdTime=Tue May 16 17:01:13 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198857, encodeId=2c8a19885e08, content=祝贺,多学科研究胰腺癌,形成规范化治疗体系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/27/136abcae2f8e58d33f28258f76f49b4f.jpg, createdBy=7e701980206, createdName=王国安, createdTime=Tue May 16 16:24:37 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=198844, encodeId=a19d19884405, content=分享分享!!!!!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue May 16 13:59:48 CST 2017, time=2017-05-16, status=1, ipAttribution=)]
    2017-05-16 明天会更好!

    分享分享!!!!!!!

    0

相关资讯

胃癌缘何成为上海第三高发的肿瘤

近日上海市疾控中心发布了上海市癌症指数——癌情通报。报告指出肿瘤已经是影响上海居民健康的主要慢性疾病之一,是上海居民的第二位死因。而在肿瘤相关死亡中胃癌位居第三。“啥,你说啥?胃癌不是‘穷病’吗?咱大上海可不穷啊!上海人可是蛮讲究饮食健康的。”在大家的印象中胃癌应该是个“穷病”,发达地区发病率低,欠发达地区发病率高。我们国家的西北地区,如甘肃、青海,是胃癌发病率最高的,然而上海作为国内经济发达地区

李斌:推广上海模式 落实家庭医生签约服务工作

4月13日,李斌充分肯定了上海等地开展家庭医生签约服务工作的经验,要求各地从6个方面做实做好家庭医生签约服务工作。

上海拟建统一预约诊疗平台 防范“黄牛”抢号囤号

上海市已正式启动全市预约诊疗服务管理平台建设项目,拟建立统一标准、分级管理的号源预约资源池,有效防范号贩子、“黄牛”现象。

上海宝宝可转诊英国!儿童医院签约英国医疗集团

据透露,圆和在中国的首家儿科医院明年将在上海成立,儿童医院将为其提供医疗技术支持,畅通疑难杂症患者的转诊通道。

国内很大儿童脑肿瘤研究组织落地上海

5月13日,中国规模最大的儿童脑肿瘤研究组织———中国儿童脑肿瘤协作组(CNOG)在沪成立。该协作组由上海交大医学院附属新华医院小儿神经外科牵头,联合国内63家医疗机构神经外科和肿瘤科以及研究所共同组建,将建设儿童肿瘤共享数据库,致力于儿童脑肿瘤治疗的临床疗效与研究推进。

挖出科研“扫地僧”上海建成10万人知名专家数据库

记者15日从上海研发公共服务平台获悉,一张全面了解全球顶尖人才的大数据网络———全球高层次科技人才数据库和信息服务平台已完成第一阶段建设。这份数据库目前整合了3.9万名全球顶尖专家、1.4万名华人顶尖专家和5万名本市科技专家,入选专家在各自领域中的排名均为前千分之一